Deep learning algorithms have been successfully used in medical image classification and 2 cancer detection. In the next stage, the technology of acquiring explainable knowledge from 3 medical images is highly desired. Herein, fully automated acquisition of explainable features 4 from annotation-free histopathological images is achieved via revealing statistical distortions 5 in datasets by introducing the way of pathologists' examination into a set of deep neural 6 networks. As validation, we compared the prediction accuracy of prostate cancer recurrence 7 using our algorithm-generated features with that of diagnosis by an expert pathologist using 8 established criteria on 13,188 whole-mount pathology images. Our method found not only the 9 findings established by humans but also features that have not been recognized so far, and 10 showed higher accuracy than human in prognostic prediction. This study provides a new field 11 to the deep learning approach as a novel tool for discovering uncharted knowledge, leading to 12 effective treatments and drug discovery. 13 (149/ 150 word) 14 15
Trained on massive amounts of annotated data, deep learning algorithms have been 1 successfully used in medical image classification and cancer detection. Esteva et al. 2 successfully used a deep neural network to categorize fine-grained images of skin tumors, 3 including malignant melanomas, at a dermatologist level 1 part of a challenge competition and found that the performance of the high-ranking algorithm 10 was comparable to that of pathologists in the detection of breast cancer metastases in 11 histopathological tissue sections of lymph nodes 4 . Currently, machine learning-enhanced 12 hardware is also being developed. Google has announced the development of an augmented 13 reality microscope based on deep learning algorithms to assist pathologists 5 . However, 14 automated acquiring explainable knowledge from medical images has not been uncharted. 15 Pathological examinations are used to provide definitive diagnoses and are one of the most 16 reliable examinations in current cancer medicine 6 , but the diagnostic pathology knowledge and 17 skills needed can only be acquired by completing a long fellowship program 7 . Although 18 machine learning-driven histopathological image analysis 4,8,9 is an attractive tool to assist 19 5 doctors, it faces two significant hurdles: the need for explainable analyses to gain clinical 1 approval and the tremendous amount of information in histopathological images 8, 10 . Acquiring 2 explainable knowledge from medical images is imperative for medicine. Furthermore, there are 3 substantial size differences between histopathological images and other medical images [1] [2] [3] 11, 12 . 4 A pathology slide contains large number of cells and the image consists of as many as tens of 5 billion pixels 8 . 6 We aimed to develop a new method to acquire explainable features from annotation-free 7 histopathological images and assessed the prediction accuracy of prostate cancer recurrence 8 using our algorithm-generated features by comparison with that of human-established cancer 9 criteria, the Gleason score by an expert in the diagnosis of prostate cancer. Results 1 First, we have developed a new method of generating key features that employs two 2 different unsupervised deep neural networks (deep autoencoders 13,14 ) at different 3 magnifications and weighted non-hierarchical clustering 15 ( Fig. 1 and Supplementary Figures   4   1 and 2) . This takes histopathological images with over 10 billion pixel features and reduces 5 them to only 100 clustered features with scores while retaining the images' core information 6 ( Fig. 2) . These clustered features can be effective for tasks such as predicting cancer recurrence, 7 understanding the contributions of particular features and automatically annotating images. In 8 the key feature generation dataset, short-term biochemical recurrence (BCR) cases were 9 considered positive purely based on the recurrence time for patients (the recurrence period 10 range: 1.7-14.4 months). No direct information regarding cancer images was provided to deep 11 neural networks.
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Next, we validated the accuracy of cancer recurrence prediction using deep learning-13 generated features by comparing the predicted results with the Gleason score, one of the most 14 crucial clinicopathological factors in the current prostate cancer practice 16 . The Gleason grading 15 system defines five architectural growth patterns, which provides information on prostate 16 cancer aggressiveness and facilitates patients' appropriate care. As prostate cancer usually 17 harbors two or more Gleason patterns, the sum of primary and secondary patterns yields the 18 Gleason score. In this paper, all images' Gleason score were evaluated by an expert 19 7 genitourinary (GU) pathologist, T. Tsuzuki (the second author). 1 Our cohort included 1,007 patients with prostate cancers who received a radical 2 prostatectomy, with a total of 13,188 whole-mount pathology slides. We excluded 115 cases 3 involving neoadjuvant therapy and 7 cases involving adjuvant therapy as well as 43 cases who 4 could not be followed up within 1 year because of hospital transfer or death due to other causes, 5 thus leaving 842 cases for analysis. Table 1 summarizes the clinical characteristics of the study 6 cohort. Cancer was more likely to recur in patients with higher prostate-specific antigen (PSA) 7 levels (P < 0.001). It was more likely to recur in patients with a higher Gleason score (≥8) than 8 in patients with a lower Gleason score (<8). Similar patterns were observed in 1-year and 5-9 year recurrence rates. No significant differences existed in the average age, height, weight, or 10 prostate weight between patients in whom cancer recurred and those in whom it did not. We 11 categorized the data for 842 patients into the following two sets: 100 patients (100 whole-mount 12 pathology images) were used to generate key features using the deep neural networks; and 742 13 (9,816 images) were used to perform the BCR predictions using these features. We applied 14 lasso 17 and ridge 18 regression analyses and a support vector machine (SVM) 19 to the clustered 15 features to predict the BCR of prostate cancer. We evaluated the areas under the receiver 16 operating characteristic curves (AUCs) with a 95% confidence interval (CI) and receiver 17 operating characteristic (ROC) curves 20,21 . Table 2 and values to the Gleason score. The AUC for BCR predictions by the deep neural networks within 1 1 year was 0.82 (95% CI: 0.766-0.873), while the Gleason score was 0.744 (95% CI: 0.672-2 0.816). Interestingly, combining both methods produced a more accurate BCR prediction [AUC, Then, we selected the images that were closest to each cluster's centroid as being 7 representative of the clustered features ( Fig. 4) . The expert GU pathologist (T. Tsuzuki) 8 analyzed these images to search for pathological meanings ( Table 3 ). In summary, the 9 pathologist found that the deep neural networks appeared to have mastered the basic concept of 10 the Gleason score, fully automatically, generating explainable key features that could be 11 understood by pathologists. Furthermore, the deep neural networks identified the features of 12 stroma in the noncancerous area as a prognostic factor, which typically have not been evaluated 13 in prostate histopathological images. We achieved fully automated acquisition of explainable features from histopathological 2 images in the raw. Our method found not only the human-established findings but also 3 previously-unrecognized pathological features, resulting in higher prediction accuracy of 4 cancer recurrence than that of diagnosis performed by an expert pathologist using human-5 established cancer criteria, the Gleason score.
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The Gleason score 22 is a unique pathological grading system, purely based on architectural 7 disorders, without considering cytological atypia. In this study, none of the cancer cells in the 8 images identified by the deep neural networks as representative of high-grade cancer showed 9 severe nuclear atypia or prominent nucleoli. Our results of the deep neural networks indicate 10 that the central ideas behind Gleason's grading system are sound.
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The most accurate BCR predictions was produced by combining the deep learning- In this study, the deep neural networks identified comprehensible key features from scratch. 1 Silver et al. reported that the AlphaGo Zero 25 program, which is solely based on reinforcement 2 learning without any human knowledge inputs, could defeat their previous AlphaGo 26 program, 3 which conducted supervised learning using human expert moves. In this study, we demonstrated 4 another algorithm that performs well, is based on deep autoencoders 13,14 , and does not need 5 human knowledge. Hopefully, this algorithm will provide a novel tool for discovering new 6 findings. In addition, our method can be applied to non-verbal information, such as that derived 7 from the subjective experience of experts, as long as it is used to classify images. For example, 8 data from patients with similar symptoms but unknown causes could be used to discover the 9 key underlying factors, resulting in more effective treatments and the development of new 10 medicines. We anticipate that our method will lead to the new design of clinical trials using 11 deep learning and therapeutic strategies and will help reduce the workloads of busy physicians 27 .
12
This study has some limitations. Our results are limited in that we did not perform 13 validation in multiple centers. A clinical trial is required to determine whether our method is 14 universally effective for improving the prediction accuracy and patient care in different areas. 15 Nonetheless, our cohort was sufficiently large and provides reliable and robust results in one 16 facility. Furthermore, we present detailed flowcharts and methods in this paper, and all 1 analyses huge medical images broadly and without oversights or bias; a human pathologist 2 analyses the disease more accurately and with a greater focus on medical importance. Each 3 approach can, therefore, complement the other. Medicine aims to save patients, and both 4 medical doctors and artificial intelligence (AI) systems can contribute to this goal. The more 5 effectively and deeply medical experts can utilize AI systems, the more patients will benefit. 6 Increasing collaboration between medical experts and informaticians will surely improve 7 outcomes for patients. Hospital (N = 1,007). We collected whole-mount pathology slides and clinical data for all 5 patients in this cohort. Of note, no patients were enrolled on clinical trials of radical 6 prostatectomy. All patients were followed and checked for the BCR every 3 months 7 postoperatively; the median follow-up duration was 72.8 months. We defined the BCR 8 following radical prostatectomy based on the European Association of Urology guidelines of 9 increasing PSA levels >0.2 ng/mL 28 . We excluded 115 cases involving neoadjuvant therapy and 10 7 cases involving adjuvant therapy as well as 43 cases who could not be followed up within 1 11 year because of hospital transfer or death due to other causes, thus leaving 842 cases for analysis.
This research was approved by the Institutional Review Boards of the Nippon Medical School 13 Hospital (reference 28-11-663) and RIKEN (reference Wako3 29-14), Japan.
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Datasets 16 We categorized the data for 842 patients into the following two sets: 100 patients (100 17 whole-mount pathology images) were used to generate key features using the deep neural 18 networks; and 742 (9,816 images) were used to perform BCR predictions using these features.
13
We carefully ensured that no direct information regarding cancer concepts was provided to deep 1 neural networks. In addition, histopathological images were not checked or annotated by 2 pathologists before key feature generation was performed by the deep neural networks. In the 3 key feature generation dataset, short-term BCR cases were considered positive purely based on 4 the recurrence time for patients (the recurrence period range: 1.7-14.4 months). To avoid bias, 5 we also used the same surgery year distribution to select negative cases. Of note, images that 6 extended beyond the edge of the cover glass were not used for key feature generation. During 7 the key feature generation process, we simply selected the largest available image in each 8 patient, without checking whether any cancer was included. 9 10 Statistical analysis 11 We compared the characteristics of patients whose cancer did or did not recur within 1 and 12 5 years postoperatively using the Fisher's exact test for categorical data and the Wilcoxon rank-13 sum test for continuous data ( Table 1) . All tests were two-tailed and were considered 14 statistically significant if P < 0.05. All statistical analyses were performed using R, version Preparation of whole-mount pathology images 18 Whole prostates were fixed in 10% formalin and embedded in paraffin. All samples were 19 sectioned at a thickness of 3 μm and stained with hematoxylin and eosin (H&E). All H&E-1 stained slides were scanned by a whole-slide imaging scanner (Hamamatsu NanoZoomer S60 2 Slide Scanner) with a 20× objective lens and were stored on a secure computer. and was inspired by the step-by-step microscopic inspection process pathologists typically use 1 for diagnosis. Step 1: We generated the key features from 100 whole-mount pathology images (100 4 cases), taken at low magnification (25x). We divided each image (considered as an image data 5 vector Si) into a set of small 128×128-pixel images Si,j using NDP.convert software 6 (Hamamatsu Photonics K.K., version 2.0.7.0). We then applied a deep autoencoder we had 7 developed for pathology images (Supplementary Figure 2) to each small image, clustering included white background areas without tissue were automatically removed. Next, we found 10 the centroid of each cluster, and calculated a score ui,j,k for each feature based on the distance 11 from each centroid di,j.k. Here, we applied the simplest possible scoring method, as follows: 12 ui,j,k = 1 if k = argmink di,j.k and 0 otherwise (k = 1,2,…,100).
Defining the total number of small images belonging to the positive and negative groups and Ii,j = Σk Ik×ui,j,k.
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Step 1 corresponds to the way pathologists search low-magnification images. where m denotes the total number of small images S'i,j,j' used for Si,j. 6 Step 2 corresponds to the way pathologists confirm their findings at higher 7 magnification. Step 3: Images that were frequently in the positive and negative groups had impact 10 scores above and below 0.5, respectively, so we defined images with impact scores above and 11 below 0.5 as having positive and negative characteristics, respectively. We then removed 12 images whose characters, based on the impact scores in Steps 1 and 2, did not match. Finally, 13 we used the total numbers of each clustered feature type for the subsequent predictions. To evaluate our approach, we predicted cancer recurrence using 9,816 whole-mount 17 pathology images (742 cases), excluding 100 cases that were used for key feature generation.
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In particular, we assessed the potential of the 100 clustered features to predict the recurrence of 19 cancer within 1 or 5 years postoperatively using Lasso 17 and Ridge 18 regression and a support 1 vector machine (SVM) 19 , all popular methods for building prediction models. In addition, we 2 created prediction models based on the application of logistic regression to an ISUP grade group 3 assessed on the basis of the Gleason score and similarly created models combining the 100 4 clustered features with the grade. If multiple images were available for a given patient, we 5 averaged each feature over all the images. To address the fact that the feature values were not 6 evenly distributed amongst patients where cancer did and did not recur, we multiplied each 7 feature value by 1 + | Ik -0.5| (see 'Key feature generation method' in the methods section), 8 which augmented the predictive power of the models. We used 10-fold cross-validation 29,30 to 9 test the prediction models, randomly dividing the whole sample set in a 1:9 ratio, using one part 10 for testing and the other nine parts for training. For each testing/training split, we used the AUC 11 metric to assess the performance of trained prediction models on the test data 20,21 . We used R 12 for the analysis, using the glmnet package (version 2.0.16) for Ridge and Lasso regression, the 13 e1071 package (version 1.7.0) for the SVM, and the cvAUC package to evaluate the AUC with 14 a CI. Step 1: First, we divide a low-magnification pathology images into smaller images, then 5 perform dimensionality reduction using a deep autoencoder followed by weighted non- Step 2: Next, we analyse high-magnification images in order to reduce the number of 10 misclassified low-magnification images. Again, we divide these into smaller images, before 11 applying a second deep autoencoder and calculating average scores for the images. (This step 12 corresponds to the way pathologists confirm their findings at a higher magnification.)
13
Step 3: We remove images where the results of Steps 1 and 2 do not match. Finally, we use the 14 total numbers of each type f clustered feature to make predictions. For example, to make cancer 15 recurrence predictions, create human-understandable features or automatically annotate images. Table 3 ). (a) 1,2,4,5,6,8,9,10: Cancers equivalent to Gleason patterns 4 or 5, which usually Step 2] (see 'Key feature generation method' in the methods section). This study was conducted by the RIKEN AIP Deep Learning Environment (RAIDEN) 2 supercomputer system for the computations. We thank the RAIDEN-supporting members at the 3 RIKEN AIP center. We also thank Prof. Takeo Kanade for his insight. This research was 4 supported by the ICT Infrastructure for the Establishment and Implementation of Artificial currently applying for patents on the method presented in this paper. This approach was inspired by the way pathologists typically conduct diagnosis via step-bystep microscopic inspection.
Step 1: First, we divide a low-magnification pathology images into smaller images, then perform dimensionality reduction using a deep autoencoder followed by weighted nonhierarchical clustering. This process reduces an image with over 10 billion-pixel features to only 100 clustered features with scores. (This step corresponds to the way pathologists search low-magnification images.)
Step 2: Next, we analyse high-magnification images in order to reduce the number of misclassified low-magnification images. Again, we divide these into smaller images, before applying a second deep autoencoder and calculating average scores for the images. (This step corresponds to the way pathologists confirm their findings at a higher magnification.)
Step 3: We remove images where the results of Steps 1 and 2 do not match. Finally, we use the total numbers of each type f clustered feature to make predictions. For example, to make cancer recurrence predictions, create human-understandable features or automatically annotate images. Step 2] (see 'Key feature generation method' in the methods section). The reported values are averages with 95% confidence interval. The bold values are the best accuracy of lasso, ridge and SVM.
*Biochemical recurrence (BCR). 
